Potential Therapies of COVID-19 Drug - A Review

Authors

  • Sakshi Singh School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar, Panjab, India
  • Navneet Khurana School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar, Panjab, India
  • Ramandeep Kaur School of Physiotherapy and Paramedical Sciences, Lovely Professional University, Jalandhar, Panjab, India
  • Suraj Bhardwaj School of Physiotherapy and Paramedical Sciences, Lovely Professional University, Jalandhar, Panjab, India
  • Himani Mehta School of Physiotherapy and Paramedical Sciences, Lovely Professional University, Jalandhar, Panjab, India
  • Neha Sharma School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar, Panjab, India

DOI:

https://doi.org/10.21276/apjhs.2021.8.4S.3

Keywords:

COVID-19, COVID-19 medicine, Covaxin, Covishield, Plasma therapy, Treatment of COVID-19.

Abstract

Coronavirus disease 2019 or novel coronavirus 2019 is referred as COVID-19. SARS-CoV-2 is the virus that causes the infection(severe acute respiratory syndrome coronavirus 2). Since the need for vaccine was critical, the government and private sector invested significantly more money in its growth. A questionnaire was distributed among people of different occupations within India and other countries to study the awareness of people on the potential therapies of COVID-19. The questionnaire was sent to 205 people and 201 responses were obtained and 4 were ignored. The study was made to analyze how many people are aware of the COVID-19 and its vaccines. We also studied and reviewed the potential therapies in COVID-19.

Downloads

Download data is not yet available.

Downloads

Published

2021-12-31

How to Cite

Sakshi Singh, Navneet Khurana, Ramandeep Kaur, Suraj Bhardwaj, Himani Mehta, & Neha Sharma. (2021). Potential Therapies of COVID-19 Drug - A Review. Asian Pacific Journal of Health Sciences, 8(4), 11–20. https://doi.org/10.21276/apjhs.2021.8.4S.3